SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing attention as investors react to its new payroll infrastructure integration with the Stellar network, fueling community speculation about a potential future partnership with Ripple. While holders remain focused on the project's real-world utility and long-term staking potential, the stock is experiencing significant volatility as market participants debate whether these announcements represent a lasting catalyst or a temporary pump.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for investors as the community debates the platform's long-term utility in DeFi and RWA integration amidst broader market volatility. Sentiment is split between those focused on ecosystem development and meme coin launches, and others raising concerns regarding network stability and historical security incidents.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

The $RAGE community is driving momentum by promoting the restoration of iconic, early-2000s era internet meme generators and tools on the Solana blockchain. Supporters are actively engaging in 'bagworking' and meme creation to build long-term conviction, positioning the project as a foundational 'OG' meme asset.

Maul Coin

Maul Coin is driving significant community engagement as holders rally behind an active developer to push for organic growth, increased visibility on trading platforms, and a long-term vision of sustained market cap expansion. The conversation is currently dominated by enthusiasts coordinating raids and social media activity to fuel a potential breakout, while simultaneously addressing skepticism from market critics.

Dunald Dump

The community is actively discussing the rapid momentum and viral potential surrounding this new meme coin, focusing on its market capitalization growth and speculative entry opportunities.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is trending as community members highlight its low market cap and ultra-limited circulating supply as potential catalysts for significant upside. Traders are actively debating the token's long-term potential compared to other projects, with many focused on accumulation and the impact that increased trading volume could have on its price action.

"What's Updog?" is a Community Led token.

UpDog

The UpDog community is rallying around the project as it approaches two years of continuous operation on the Solana blockchain. Investors are actively sharing swap instructions and engaging in lighthearted community banter to maintain visibility and momentum.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors monitor its lead clinical asset in trials for hidradenitis suppurativa and analyze the company's recent pipeline developments. The community is actively debating the stock's potential for an asymmetric move based on clinical data milestones, while keeping a close eye on high daily trading volumes and ongoing institutional interest.

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

Nutanix Inc - Ordinary Shares - Class A

Nutanix Inc 

Nutanix is surging following a strong quarterly earnings report that exceeded top and bottom-line expectations, coupled with a strategic multi-year partnership and equity investment from AMD to develop AI infrastructure. Investors are actively debating the stock's future trajectory, weighing the excitement around the AI collaboration against the company's slightly lowered guidance and ongoing supply chain considerations.

Suncor Energy, Inc. is an integrated energy company, which engages in the development of petroleum resource basins. It operates through the following segments: Oil Sands, Exploration and Production, Refining and Marketing, and Corporate and Eliminations. The Oil Sands segment includes oil sands operations which includes mining, extraction, upgrading, in situ and related logistics, blending and storage assets. The Exploration and Production segment includes offshore operations off the east coast of Canada and onshore assets in Libya and Syria, and marketing and risk management of crude oil. The Refining and Marketing segment focuses on refining and supply operations refine crude oil and intermediate feedstock into a wide range of petroleum and petrochemical products, and marketing of refined petroleum products to retail customers across Canada and US. The Corporate and Eliminations segment includes activities not directly attributable to any other operating segment. The company was founded in 1917 and is headquartered in Calgary, Canada.

Suncor Energy, Inc.

Suncor Energy is trending due to the completion of its strategic acquisition of TotalEnergies' remaining stake in the Fort Hills oil-sands mine, a move aimed at bolstering long-term production and reserves. Investors are actively discussing the company's operational performance, its ability to navigate volatile crude prices, and ongoing expectations for enhanced shareholder returns through disciplined capital allocation and potential dividend growth.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Semaglutide Ruling Sparks Generic Pharma Boom

… oncology drugs . India's revocation of Novartis … Natco Pharma to launch its version of Roche … Natco Pharma to launch a generic version of Roche … Zydus Lifesciences, Natco Pharma , Alkem Laboratories, and Torrent Pharmaceuticals have developed …

Alkem Laboratories launches semaglutide in India at ₹450 per week, eyes booming weight-loss market

… demand for weight-loss drugs . The patent expiry of semaglutide … active ingredient in blockbuster drugs like Ozempic and Wegovy … to tap the opportunity. Sun Pharmaceutical Industries has launched … 4,200 a month. Glenmark Pharmaceuticals is offering " …

Rs 325–4,200/month: Dr Reddy’s, Sun Pharma, Glenmark kick off generic semaglutide price war

… Reddy’s Laboratories, Sun Pharma , Glenmark Pharmaceuticals , Alkem Laboratories, Zydus Lifesciences … , and Natco Pharma . Eris Lifesciences, which has a … first Indian pharma company to receive approval from the Drugs Controller General …

Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss market

Alkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is available under brand names like Semasize and Obesema. The injection is administered once weekly. Alkem offers a pre-filled pen for a month's dosage at Rs 1,800. This makes the weekly cost Rs 450.

Brief Healthcare: Cadrenal Therapeutics Inc - In December 2025 and more

In this briefing: Cadrenal Therapeutics Inc - In December 2025 Actinogen Medical — XanaMIA passes interim analysis and marches on Alkem Laboratories: Occlutech M&A to Support Medtech Aspiration. Maintain ADD Hybridan Small Cap Feast: 12 February 2026 Vieworks (100120 KQ/Buy)Steady Performance, Attractive Valuation 1. Cadrenal Therapeutics Inc - In December 2025 In December 2025, Cadrenal Therapeutics, Inc. (CVKD) announced it had acquired VLX-1005, a first-in-class, selective 12-lipoxygenase (12-LOX) inhibitor that is being developed for heparin-induced thrombocytopenia (HIT), a rare, immune-mediated thrombotic disorder with high morbidity and mortality. VLX-1005 is designed to address the underlying platelet-driven inflammatory and prothrombotic mechanisms of HIT rather than coagulation alone. The compound has completed Phase 1 clinical development with a favorable safety and pharmacokinetic profile and has generated encouraging Phase 2 proof-of-concept data indicating a potential reduction in thrombotic complications. 2.

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Current Price	5,271.00
Prev Close	5,250.50
Open	5,210.50
Dividend Yield	0.92%
50-Day Moving Average	5,530.02
Beta	-0.01
Avg. Volume	114,906.47
PE Ratio	26.54

52-Week High	5,933.50
52-Week Low	4,611.85
Market Capitalization	628.57B
EPS (Annual)	181.11
Price to Book	4.71
Revenue Per Employee	5.66M

ALKEM.NSE
Alkem Laboratories Limited

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALKEM.NSE News

ALKEM.NSEAlkem Laboratories Limited